(S1 (S (NP (NP (NN Cell) (NN culture)) (CC and) (NP (NN stimulation)))))
(S1 (S (S (NP (DT All) (NN cell) (NNS lines)) (VP (VBD were) (VP (VBN maintained) (PP (IN at) (NP (ADJP (CD 5) (NN %)) (NN CO2))) (PP (IN in) (NP (NP (NN RPMI) (CD 1640) (NN medium)) (PP (IN with) (NP (NP (NP (ADJP (CD 1) (NN %)) (NN glutamine)) (PRN (-LRB- -LRB-) (NP (NNP Gibco/BRL) (NNP Eggenstein) (, ,) (NNP Germany)) (-RRB- -RRB-))) (VP (VBN supplemented) (PP (IN with) (NP (NP (NP (ADJP (CD 10) (NN %)) (JJ fetal) (NN calf) (NN serum)) (PRN (-LRB- -LRB-) (NP (NN Gibco/BRL)) (-RRB- -RRB-))) (, ,) (NP (NP (ADJP (CD 1) (NN %)) (NN penicillin/streptomycin)) (PRN (-LRB- -LRB-) (NP (NNP Biochrom) (, ,) (NNP Berlin) (, ,) (NNP Germany)) (-RRB- -RRB-))))))))))))) (. .)))
(S1 (S (S (SBAR (WHADVP (WRB When)) (S (VP (VBN indicated)))) (, ,) (NP (NNS cells)) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NP (NP (NN 5-aza-2-deoxycytidine)) (PRN (-LRB- -LRB-) (NP (NN AzadC)) (-RRB- -RRB-))) (CC or) (NP (NP (NN 5-azacytidine)) (PRN (-LRB- -LRB-) (NP (NN AzaC)) (-RRB- -RRB-))))) (PRN (-LRB- -LRB-) (NP (NN Sigma)) (, ,) (NP (NP (NNP Taufkirchen)) (, ,) (NP (NNP Germany))) (-RRB- -RRB-)) (PP (IN for) (NP (JJ different) (NN time) (NNS periods)))))) (. .)))
(S1 (S (S (S (VP (VBG Owing) (PP (TO to) (NP (PRP$ their) (JJ chemical) (NN instability))))) (NP (JJ fresh) (NNS substances)) (VP (VBD were) (VP (VBN re-added) (NP (DT every) (CD 24) (NN h))))) (. .)))
